Every time I read a news report like the one below my heart sinks a bit.
The Washington Post reported on June 5 that Pfizer and Amgen decided not to pursue the drug Enbrel for Alzheimer’s and not to publish data from preliminary investigations.
Pfizer and Amgen’s decision inspired disappointment with Maria C. Carrillo, Ph.D., chief science officer for the Alzheimer’s Association.
Carrillo wrote: “Any science that has promise for Alzheimer’s disease and other dementias and is not genuinely pursued, or shared with the research community, does a disservice to the millions of individuals facing the disease today and in the future.”
Alzheimer’s is a personally devastating and fatal disease, the sixth leading cause of death in the United States, with the number of people afflicted increasing daily. No stone should be left unturned. The expectation of the Alzheimer’s Association and our millions of constituents is that every possible path is pursued thoroughly and aggressively with people living with the disease as a priority.
We must find a cure for the most expensive disease in America. Alzheimer’s has no survivors. Every 65 seconds someone develops this disease. There are more than 6 million people in the United States living with Alzheimer’s and other dementia-related diseases.
One out of every six people age 65 and older will have Alzheimer’s.
Please join the fight by joining us for a fundraising event for Alzheimer’s disease research on Wednesday at Kearney’s Ramada Inn. The Rock ‘N’ Remember Elvis Tribute, starring Joseph Hall, begins with a social at 5:30 p.m., followed at 7:15 p.m. by Hall’s performance. Hall is regarded as one of the most popular entertainers in the Midwest. He was a runner-up on America’s Got Talent.
Tickets to Wednesday’s fundraiser are available at Solid Rock in Kearney, Joy’s Floral in Minden and My Fair Lady in Holdrege or by calling 308-743-2517. Tickets, at $25 each, will be available through Monday.
Please join us.
Susan Bigg, Kearney